Financial reports
10-K
2015 FY
Annual report
26 Feb 16
10-Q
2015 Q3
Quarterly report
12 Nov 15
10-Q
2015 Q2
Quarterly report
31 Jul 15
10-Q
2015 Q1
Quarterly report
13 May 15
10-K
2014 FY
Annual report
20 Mar 15
10-Q
2014 Q3
Quarterly report
14 Nov 14
10-Q
2014 Q2
Quarterly report
8 Aug 14
10-K/A
2013 FY
Annual report (amended)
18 Jun 14
10-K/A
2013 FY
Annual report (amended)
18 Jun 14
Current reports
8-K
SciVac Therapeutics and VBI Vaccines Announce Completion of Merger Transaction
9 May 16
8-K
Entry into a Material Definitive Agreement
9 May 16
8-K
VBI Vaccines to Present at the Bloom Burton Healthcare
28 Apr 16
8-K
VBI Vaccines and SciVac Therapeutics Announce Effectiveness of Registration Statement on Form F-4
14 Apr 16
8-K
Other Events
30 Mar 16
8-K
VBI Vaccines to Present at the World Vaccine Congress Washington
29 Mar 16
8-K
Entry into a Material Definitive Agreement
21 Mar 16
8-K
VBI Vaccines Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference
7 Mar 16
8-K
VBI Vaccines to Present at the ROTH Conference
3 Mar 16
8-K
Entry into a Material Definitive Agreement
2 Mar 16
Registration and prospectus
15-12G
Securities registration termination
16 May 16
POS AM
Prospectus update (post-effective amendment)
9 May 16
POS AM
Prospectus update (post-effective amendment)
9 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
9 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
9 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
9 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
9 May 16
25-NSE
Exchange delisting
6 May 16
425
Business combination disclosure
2 May 16
425
Business combination disclosure
14 Apr 16
Proxies
DEF 14A
Definitive proxy
8 Apr 16
DEFA14A
Additional proxy soliciting materials
26 Oct 15
DEF 14A
Definitive proxy
15 Apr 15
DEFM14A
Proxy related to merger
30 Jun 14
PRER14A
Preliminary revised proxy
18 Jun 14
PREM14A
Preliminary proxy related to merger
9 May 14
DEF 14A
Definitive proxy
18 Oct 13
PRER14A
Preliminary revised proxy
18 Sep 13
PRER14A
Preliminary revised proxy
6 Sep 13
PRER14A
Preliminary revised proxy
23 Aug 13
Other
EFFECT
Notice of effectiveness
11 May 16
EFFECT
Notice of effectiveness
11 May 16
CT ORDER
Confidential treatment order
14 Mar 16
CT ORDER
Confidential treatment order
14 Mar 16
EFFECT
Notice of effectiveness
2 Sep 15
UPLOAD
Letter from SEC
1 Sep 15
CORRESP
Correspondence with SEC
1 Sep 15
EFFECT
Notice of effectiveness
10 Jul 15
CORRESP
Correspondence with SEC
8 Jul 15
CT ORDER
Confidential treatment order
23 Jun 15
Ownership
SC 13D/A
ARCH VENTURE FUND VI LP
25 Jul 23
SC 13D/A
ARCH VENTURE FUND VI LP
6 May 20
SC 13G/A
Vbi Vaccines Inc.
12 Feb 20
4
STEVEN GILLIS
23 Sep 19
SC 13G/A
Vbi Vaccines Inc.
11 Feb 19
SC 13G
Vbi Vaccines Inc.
29 May 18
SC 13D/A
Vbi Vaccines Inc.
9 Feb 18
3
Jeff Baxter
19 Apr 17
3
Michel DeWilde
19 Apr 17
4
Michel DeWilde
19 Apr 17